From: Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA
Treatment group
Number of
dogs
Tablet consumed free choice or with small amount of food (%)
Manually dosed [pilled] (%)
Credelio Plus tablets
159
1277 (81.8%)
285 (18.2%)